🟢 Hims & Hers Health is trading 3% up today as shares stabilize after FDA peptide vote selloff

Hims & Hers Health is trading 3% up today at €25.94 as shares stabilize following last week’s sharp drop.

• The stock previously cratered 18% to €25.18 after a mixed FDA Pharmacy Compounding Advisory Committee vote on seven peptides central to the company’s growth strategy.
• Today’s rebound appears to be a partial recovery as investors reassess regulatory risks and broader healthcare sentiment improves.